Maculus Therapeutix is a Silicon Valley, California based preclinical-stage biopharmaceutical company focused on finding practical solutions to treat chronic diseases of the eye (retina and optic nerve) such as wetAMD (Age related Macular degeneration) and DME in the Ophthalmology space. Maculus Therapeutix has developed ONE YEARLY injection solution to treat Age related Macular Degeneration (wetAMD) and Diabetic Macular Edema (DME) etc. instead of the standard of care of 10-12 injections